Investmark Advisory Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Investmark Advisory Group's PFE Position: Q1 2026 in Review
Investmark Advisory Group reduced its Pfizer (PFE) stake by 92% in Q1 2026, selling an estimated $2.73M and leaving 8,728 shares worth $245K. The position accounts for 0.1% of the portfolio, ranked #120.
Investmark Advisory Group first reported a position in PFE in Q4 2021 and has held it in 18 quarters since. The position peaked at $3.77M in Q4 2022. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Investmark Advisory Group held 8,728 shares of Pfizer worth $245K as of Q1 2026.
- Investmark Advisory Group sold 102,668 Pfizer shares in Q1 2026, an estimated $2.73M.
- Pfizer made up 0.1% of Investmark Advisory Group's portfolio in Q1 2026, its #120 holding.
- Investmark Advisory Group first reported a position in Pfizer in Q4 2021 and has held it in 18 quarters since.
- Investmark Advisory Group's Pfizer position peaked at $3.77M in Q4 2022.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Investmark Advisory Group's 13F filing for Q1 2026, filed 15 May 2026.